Factors Influencing the Decision to Start Renal Replacement Therapy: Results of a Survey Among European Nephrologists
Moniek W.M. van de Luijtgaarden(Amsterdam UMC Location University of Amsterdam), Kitty J. Jager(Amsterdam University Medical Centers), Christoph Wanner(Universitätsklinikum Würzburg), Patrik Finne(Hospital District of Helsinki and Uusimaa), Willem Jan W. Bos(St. Antonius Ziekenhuis), José Luis Górriz(Universitat de València), Wim Van Biesen(Ghent University Hospital), Liliana Gârneaţă(Carol Davila University of Medicine and Pharmacy), Vianda S Stel(Amsterdam UMC Location University of Amsterdam), Giovanni Cancarini(Brescia University), Cécile Couchoud(Agence de la Biomédecine), Marlies Noordzij(University of Amsterdam), Friedo W. Dekker(Leiden University Medical Center), Charles Tomson(Freeman Hospital), Olivera Stojceva-Taneva(PHI University Psychiatric Clinic - Skopje), David Ansell(University of Glasgow), Christos Iatrou(General Hospital of Nikea), Svjetlana Čala(University of Zagreb)
Cited by 63
Related Papers
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
|New England Journal of Medicine|2016|3.6k
Clinical practice guideline on diagnosis and treatment of hyponatraemia
|Intensive Care Medicine|2014|1k
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
|The Lancet|2022|1k
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
|New England Journal of Medicine|2013|990
A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases
|Kidney International|2019|886